다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Cyclacel Pharmaceuticals Inc (CYCC)
Cyclacel Pharmaceuticals Inc (CYCC) 뉴스

CYCC

Cyclacel Pharmaceuticals (CYCC)

Cyclacel Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CYCC

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/04	21:00	GlobeNewswire Inc.	Cyclacel’s Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2024/06/03	21:00	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Reports New Clinical Data at 2024 ASCO Annual Meeting Highlighting Oral Fadraciclib’s Potential as a Precision Medicine for Cancer	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2024/05/15	05:05	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2024/05/08	22:15	GlobeNewswire Inc.	Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2024/05/03	05:30	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2024/05/01	02:51	AllPennyStocks.com	$8 Million Private Placement Announcement Sends Biotech Flying	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2024/04/30	20:00	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2024/04/01	22:15	GlobeNewswire Inc.	Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2024/03/20	05:05	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2024/03/19	20:27	IH Market News	US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2024/03/14	05:05	GlobeNewswire Inc.	Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2024/03/07	23:15	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2024/03/06	23:15	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2024/02/20	23:15	GlobeNewswire Inc.	Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2024/01/30	23:15	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2023/12/18	23:00	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B and MTAP Deletions	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2023/12/13	06:05	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Announces Reverse Stock Split	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2023/11/30	23:15	GlobeNewswire Inc.	Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SEC	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2023/11/29	07:15	GlobeNewswire Inc.	Cyclacel Receives Notification of Deficiency From Nasdaq Regarding Timely Filing of Quarterly Report on Form 10-Q	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2023/11/07	23:15	GlobeNewswire Inc.	Cyclacel Pharmaceuticals to Release Third Quarter 2023 Financial Results	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2023/08/10	05:05	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2023/08/03	22:15	GlobeNewswire Inc.	Cyclacel Pharmaceuticals to Release Second Quarter 2023 Financial Results	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2023/06/15	05:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2023/05/12	06:16	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2023/05/12	05:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2023/05/12	05:05	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2023/05/05	05:08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2023/05/04	22:15	GlobeNewswire Inc.	Cyclacel Pharmaceuticals to Release First Quarter 2023 Financial Results	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2023/05/03	22:15	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Announces Receipt of $4.7 Million R&D Tax Credit	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc
2023/03/13	19:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CYCC	Cyclacel Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:CYCC

1 2 3 4 5 6 7 8 9 10 다음 >>

JP Morgan Chase

Invesco QQQ Trust Series 1

US Dollar vs Euro

Bank of America

American Express

Deutsche Telekom (QX)

Financial Select Sector

Health Care Select Sector

US Dollar vs Yen

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관